Drugs / maltodextrin
maltodextrin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05603364 | Nov 2022 → Jun 2023 | — | Nanjing First Hospital, Nanjing Medical University | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05188222 | Dec 2025 → Dec 2026 expected | heart disorder | Jewish General Hospital | Not yet recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04962776 Comparator | Aug 2021 → Jan 2027 expected | — | Ain Shams University | Recruiting | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | maltodextrin | “clear carbohydrate drink (12.5 g/100 mL maltodextrin, 50 kcal/100 mL)” NCT04962776 ↗ |
| Known as | Dextri-maltose | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Known as | Glucidex | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Known as | Glucodry | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Known as | Leppin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Known as | Maldex | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Known as | Maldrin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Known as | Polycal | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Known as | Star-dri | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107951 ↗ |
| Route | Oral | “Patients in the CHON group will be given 400 mL of a clear carbohydrate drink” NCT04962776 ↗ |